IRIS
LUGHEZZANI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.181
EU - Europa 1.902
AS - Asia 1.038
AF - Africa 336
SA - Sud America 26
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 12
Totale 11.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.113
SG - Singapore 562
FI - Finlandia 480
IE - Irlanda 379
NG - Nigeria 323
CN - Cina 300
IT - Italia 236
DE - Germania 230
FR - Francia 185
NL - Olanda 96
GB - Regno Unito 85
SE - Svezia 74
TR - Turchia 67
CA - Canada 64
IN - India 30
RU - Federazione Russa 25
IL - Israele 23
CL - Cile 17
CZ - Repubblica Ceca 17
MK - Macedonia 17
BE - Belgio 16
AU - Australia 14
RO - Romania 13
JP - Giappone 11
A2 - ???statistics.table.value.countryCode.A2??? 9
EG - Egitto 9
HK - Hong Kong 9
ES - Italia 8
PH - Filippine 8
CH - Svizzera 6
IR - Iran 6
PL - Polonia 6
BR - Brasile 5
AT - Austria 4
DK - Danimarca 4
TW - Taiwan 4
UA - Ucraina 4
AR - Argentina 3
BD - Bangladesh 3
EU - Europa 3
MD - Moldavia 3
NO - Norvegia 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
BG - Bulgaria 1
GE - Georgia 1
HU - Ungheria 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
PS - Palestinian Territory 1
TH - Thailandia 1
UG - Uganda 1
VE - Venezuela 1
Totale 11.509
Salva come PNG Salva come JPEG
Città #
Wilmington 1.815
Chandler 1.306
San Mateo 715
Ann Arbor 512
Helsinki 479
Dublin 378
Singapore 372
Leawood 329
Lawrence 326
Princeton 326
Benin City 323
Shanghai 262
Boardman 218
Ashburn 189
Fairfield 186
Woodbridge 186
Paris 182
New York 149
Milan 125
Amsterdam 86
London 74
Kocaeli 66
Toronto 57
Seattle 45
San Diego 41
Norwalk 35
Santa Clara 31
Los Angeles 29
Pune 25
Dallas 24
Munich 20
Falls Church 18
Phoenix 17
Brussels 15
Des Moines 15
Falkenstein 14
Redmond 14
Monmouth Junction 13
Frankfurt am Main 12
Olomouc 11
Moscow 10
Andover 9
Skopje 9
Abbiategrasso 8
Terracina 8
Brno 6
Clearwater 6
Guangzhou 6
Las Vegas 6
Redwood City 6
Siracusa 6
Bitola 5
Cairo 5
Cambridge 5
Henderson 5
Santiago 5
Meppel 4
Novokuznetsk 4
Rome 4
Samarate 4
Trieste 4
Alexandria 3
Augusta 3
Berlin 3
Buenos Aires 3
Büdelsdorf 3
Chisinau 3
Gunzenhausen 3
Jacksonville 3
Logan 3
Melbourne 3
Olongapo City 3
Prilep 3
Saint Louis 3
Saint Paul 3
St Petersburg 3
Tappahannock 3
Umeå 3
Zhengzhou 3
Ancona 2
Barcelona 2
Beijing 2
Central 2
Chicago 2
Council Bluffs 2
Den Haag 2
Dhaka 2
Eden Prairie 2
Esslingen am Neckar 2
Florence 2
Gdansk 2
Hanoi 2
Hialeah 2
Hsinchu 2
Kawasaki 2
Kemerovo 2
La Canada Flintridge 2
Las Pinas 2
Mabalacat 2
Pamplona 2
Totale 9.261
Salva come PNG Salva come JPEG
Nome #
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 138
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 135
137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project) 101
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 76
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 74
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 70
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 65
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 64
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 64
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 63
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 62
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 62
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 61
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 60
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 60
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 60
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 60
[Focal therapy and prostate cancer]. 58
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 56
The Management of Small Renal Masses: Renal Anatomy and Physiology 56
Comparison of PHI (Prostate Health Index) and PCA3 assay in the prediction of prostate biopsy (PBx) outcome in patients who have undergone initial and repeated prostatic biopsies 55
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 55
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 55
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 55
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 54
MAGNETIC RESONANCE IMAGING ALONE SHOULD NOT BE CONSIDERED AS A STAND-ALONE TEST FOR DISEASE RECLASSIFICATION OF MEN IN ACTIVE SURVEILLANCE 53
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 53
P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDY 53
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States 53
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 53
How Should We Report Incontinence After Radical Prostatectomy? 52
MIDDLE TERM FOLLOW-UP RESULTS OF MAGNETIC RESONANCE IMAGING EVALUATION AFTER FOCAL THERAPY FOR PROSTATE CANCER 52
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolò Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. 51
INTRAFASCIAL TECHNIQUE OFFERS IMPROVED FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH BILATERAL NERVE SPARING ROBOTIC RADICAL PROSTATECTOMY 51
Pyeloplasty using the novel da Vinci single site robotic platform for the surgical treatment of uretero-pelvic junction obstruction: The technique 51
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 51
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 51
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 51
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 51
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma 51
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY 51
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 51
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 50
Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms? 50
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 50
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 50
Complications and Quality of Life After Template-assisted Transperineal Prostate Biopsy in Patients Eligible for Focal Therapy 50
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 50
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 50
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 50
A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA 49
Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223-5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction 48
SENSITIVITY OF [-2]PROPSA AS AN ULTRASENSITIVE PSA SURROGATE FOR THE PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: AN OBSERVATIONAL COHORT STUDY 48
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 48
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma 48
THE EFFECT OF PREOPERATIVE CANCER AGGRESSIVENESS ON LEARNING CURVE AMONG HIGH VOLUME SURGEONS PERFORMING RADICAL RETROPUBIC PROSTATECTOMY. 47
UROLOGIST LEARNING CURVE HAS AN IMPACT ON INCREASING PROBABILITY OF CLINICALLY SIGNIFICANT CANCER DETECTION RATE AT MPMRI-TRUS FUSION TARGET BIOPSY: A PROSPECTIVE STUDY IN A SINGLE HIGH VOLUME INSTITUTION 47
Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project 47
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 47
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolo Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.022 47
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 47
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 46
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 46
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 46
POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON-ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS 46
Is Robotic Surgery Unnecessary for Adrenalectomy? Weighting the Pros and Cons of the Robotic Approach 45
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 45
Primary diagnosis of prostate cancer: potential role of Ga-68-Prostate Specific Membrane Antigen PET/CT 45
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 45
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 45
A Population-based Comparison of Cancer-control Rates Between Radical and Partial Nephrectomy for T1A Renal Cell Carcinoma 45
A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma 45
LIQUID BIOPSY BY PROSTATE-DERIVED TUMOR CELLS ENRICHED FROM SEMINAL FLUID (SF): THE SEMEN PROSTATE CANCER TUMOR ELEMENTS (SPECTRE) PROJECT. 45
NEW CONCEPTION FOR FLEXOR VUE DEFLECTING ENDOSCOPIC SYSTEM USE, IN ORDER TO IMPROVE STONE FREE RATE (SFR) AFTER RIRS: PRELIMINARY RESULTS FROM A SINGLE CENTRE STAGE 2A STUDY 45
Surgery illustrated--Surgical Atlas. Robotic radical cystectomy in the male. 44
ABSENCE OF LEARNING CURVE IMPACT MAY LET MRI-TRUS FUSION GUIDED BIOPSY UP FOR EARLY DIAGNOSIS OF PROSTATE CANCER 44
SHOULD WE CONTINUE TO BIOPSY MEN WITH PI-RADS III AFTER PREVIOUS NEGATIVE BIOPSY? 44
Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy 44
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 44
The relationship between continence and perineal body tone before and after radical prostatectomy: A pilot study 43
Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy 43
Isoform [-2]proPSA (p2PSA) and its derivates, %p2PSA and PHI values differ between BPH, ASAP, HG-PIN and PCa in a set of contemporary men undergoing prostate biopsy 43
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 43
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 43
DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER 43
A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma 43
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer 43
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 43
[The added value of robotic surgery]. 43
COMPARISON BETWEEN PCA3 AND PHI SPECIFICTY AND SENSITIVITY IN PREDICTING THE PRESENCE OF CANCER AT INITIAL OR REPEAT BIOPSY 42
Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar 42
The Surgical Learning Curve for One-stage Anterior Urethroplasty: A Prospective Single-surgeon Study 42
EFFECTIVENESS OF PRE-OPERATIVE PELVIC FLOOR MUSCLE TRAINING FOR POST-PROSTATECTOMY EARLY CONTINENCE RECOVERY 42
Intra-operative frozen section analysis to increase the rate of nerve-sparing procedures without compromising cancer control: Results from a contemporary population of patients treated with robotic assisted radical prostatectomy 42
EXTERNAL VALIDATION OF A PROSTATE HEALTH INDEX ( PHI) BASED NOMOGRAM FOR PREDICTING PROSTATE CANCER AT EXTENDED BIOPSY IN A EUROPEAN MULTICENTER POPULATION 42
NEPHRON SPARING SURGERY FOR THE TREATMENT OF SMALL RENAL MASSES: COMPARISON BETWEEN OPEN PARTIAL NEPHRECTOMY, LAPAROSCOPIC PARTIAL NEPHRECTOMY AND LAPAROSCOPIC CRYOABLATION 42
SENSITIVITY OF [-2]PROPSA (P2PSA) MEASUREMENTS FOR PREDICTION OF BIOCHEMICAL RECURRENCE (BCR) IN MEN AFTER RADICAL PROSTATECTOMY: A 3-YEARS PROSPECTIVE COHORT STUDY 42
THE EUROPEAN NETWORK FOR THE STUDY OF ADRENAL TUMORS STAGING SYSTEM IS PROGNOSTICALLY SUPERIOR TO THE INTERNATIONAL UNION AGAINST CANCER STAGING SYSTEM: A NORTH AMERICAN VALIDATION 42
Female robotic radical cystectomy. 41
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin: experience of a single center 41
Totale 5.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020135 0 0 0 0 0 0 0 0 0 0 0 135
2020/20213.361 12 21 24 16 38 1.074 439 209 772 368 2 386
2021/20221.679 65 38 31 366 17 21 48 253 151 208 425 56
2022/20233.986 721 117 401 402 378 310 16 291 668 380 259 43
2023/20242.274 183 265 446 116 63 201 139 173 39 42 231 376
2024/2025378 90 79 48 71 90 0 0 0 0 0 0 0
Totale 11.813